MannKind (MNKD) PT Raised to $4 at BTIG As Partner Announces Positive Tyvaso Data
Tweet Send to a Friend
BTIG analyst, Robert Hazlett, raised the price target on MannKind (NASDAQ: MNKD) to $4.00 (from $3.00) after the company announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
